top of page

BackTable / Tumor Board / Podcast / Episode #23

Renal Cancer Management: Tumor Board Discussion & Treatments

with Dr. Raquib Hannan, Dr. Brandon Manley and Dr. Rana McKay

Kidney cancer management is evolving. How are experts adapting? In this installment of BackTable Tumor Board, Dr. Brandon Manley (Urologic Oncology, Moffitt Cancer Center), Dr. Raquibul Hannan (Radiation Oncology, UT Southwestern), and Dr. Rana McKay (Medical Oncology, UC San Diego) join guest host Mark Ball (Urologic Oncology, National Cancer Institute) to share their multidisciplinary perspectives on challenging, real-world kidney cancer cases.

This podcast is supported by:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Renal Cancer Management: Tumor Board Discussion & Treatments with Dr. Raquib Hannan, Dr. Brandon Manley and Dr. Rana McKay on the BackTable Tumor Board Podcast
Ep 23 Renal Cancer Management: Tumor Board Discussion & Treatments with Dr. Raquib Hannan, Dr. Brandon Manley and Dr. Rana McKay
00:00 / 01:04

BackTable, LLC (Producer). (2025, September 23). Ep. 23 – Renal Cancer Management: Tumor Board Discussion & Treatments [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Mark Ball on the BackTable Tumor Board Podcast

Dr. Mark Ball is an attending surgeon at the Urologic Oncology Branch of the National Cancer Institute and Associate Program Director of the Urologic Oncology Fellowship Program in Bethesda, Maryland.

Dr. Raquibul Hannan on the BackTable Urology Podcast

Dr. Raquibul Hannan is the chief of the genitourinary radiation oncology service at UT Southwestern in Dallas, Texas.

Dr. Brandon Manley on the BackTable Tumor Board Podcast

Dr. Brandon Manley is a urologic oncologist at Moffitt Cancer Center in Tampa, Florida.

Dr. Rana McKay on the BackTable Urology Podcast

Dr. Rana McKay is a medical oncologist and associate professor at UC San Diego Health in California.

Synopsis

The conversation covers diagnostic dilemmas, navigating the treatment options of surgery, systemic therapy, and radiation, and the importance of a multidisciplinary approach. Through detailed case reviews, the panel highlights practical pearls, emerging clinical trials, and collaborative approaches that exemplify modern kidney cancer care.

Timestamps

00:00 - Introduction
02:20 - Case 1 (Incidental Renal Mass)
16:52 - Case 2 (Bilateral Renal Masses)
37:22 - Case 3 (Locally Advanced Renal Mass)
56:34 - Case 4 (Symptomatic, Metastatic Disease)
01:14:00 - Final Takeaways

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft on the BackTable Tumor Board Podcast
Keynote-689: Implementation & Multidisciplinary Care for Immunotherapy in Head & Neck Cancer with Dr. Adam Luginbuhl, Dr. Jennifer Johnson, Dr. Mihir Patel and Dr. Siddharth Sheth on the BackTable Tumor Board Podcast
Getting Started in Interventional Oncology: Tips for Starting Your Career with Dr. Sid Padia, Dr. Kevin Burns, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy on the BackTable Tumor Board Podcast
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Biopsy Podcasts
Oncology Podcasts
Radiation Oncology Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page